Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Total Assets : ¥1,877.3 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Cheng Yi Pharmaceutical Co Total Assets?

Zhejiang Cheng Yi Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥1,877.3 Mil.

During the past 12 months, Zhejiang Cheng Yi Pharmaceutical Co's average Total Assets Growth Rate was 7.00% per year. During the past 3 years, the average Total Assets Growth Rate was 12.10% per year. During the past 5 years, the average Total Assets Growth Rate was 20.20% per year. During the past 10 years, the average Total Assets Growth Rate was 22.90% per year.

During the past 13 years, Zhejiang Cheng Yi Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 43.20%. The lowest was -0.30%. And the median was 22.60%.

Total Assets is connected with ROA %. Zhejiang Cheng Yi Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 6.94%. Total Assets is also linked to Revenue through Asset Turnover. Zhejiang Cheng Yi Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.08.

Zhejiang Cheng Yi Pharmaceutical Co Total Assets Historical Data

The historical data trend for Zhejiang Cheng Yi Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Cheng Yi Pharmaceutical Co Total Assets Chart

Zhejiang Cheng Yi Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

980.25

1,207.95

1,322.49

1,719.09

1,892.77

Zhejiang Cheng Yi Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															1,815.72	1,791.17	1,833.98	1,892.77	1,877.30

Zhejiang Cheng Yi Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Zhejiang Cheng Yi Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	1196.612	+	696.154
	=	1,892.8

Zhejiang Cheng Yi Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	1229.356	+	647.945
	=	1,877.3

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Total Assets Explanation

Total Assets is connected with ROA %.

Zhejiang Cheng Yi Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	130.74	/	( (1892.766	+	1877.301)	/ 2 )
	=	130.74	/	1885.0335
	=	6.94 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Zhejiang Cheng Yi Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	153.058	/	( (1892.766	+	1877.301)	/ 2 )
=	153.058	/	1885.0335
=	0.08

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Zhejiang Cheng Yi Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Zhejiang Cheng Yi Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Cheng Yi Pharmaceutical Co Ltd (SHSE:603811) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

No. 118, Chemical Road, Dongtou District, Zhejiang Province, Wenzhou, CHN, 325700

Website

http://www.chengyipharma.com

Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.

Executives

Ke Ze Hui	Director
Ren Bing Jun	Director
Yan Yi Yi	Director
Ceng Huan Qun	Director
Li Shi Sheng	Director
Qiu Ke Rong	Director
Lv Sun Zhan	senior management
Zhang Gao Qiao	Supervisors
Zhang Zhi Hong	senior management
Mao Li Ping	senior management
Zhuang Xiao Ping	Director
Lin Xin Chen	senior management
Shen Ai Lan	Director
Zhang Fu Fu	Supervisors

Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Headlines

No Headlines